SCHEMBL13435786

SCHEMBL13435786

COc1ccc(CN2C(=O)[C@@H]3[C@H]2[C@@H](O)CN3C(=O)OCc2ccccc2)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 5/20 0.48
TDP1 Q9NUW8 2/20 0.48
GAA P10253 1/20 0.48
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 1/20 0.43
POLB P06746 2/20 0.42
PRNP P04156 1/20 0.41
F2 P00734 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8507826 0.85 ALDH1A1 (0.50) ALDH1A1KDM4ETDP1GAATP53
SCHEMBL9031709 0.84 NPC1 (0.47) TP53LMNAMEN1KMT2A
SCHEMBL4387155 0.75 CACNA1G (0.53) ALDH1A1KDM4ETDP1GAATP53
SCHEMBL27530722 0.75 CACNA1G (0.53) ALDH1A1KDM4ETDP1GAATP53
SCHEMBL11607489 0.74 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1GAASMN1; SMN2
SCHEMBL11607494 0.74 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1GAASMN1; SMN2
SCHEMBL11607480 0.74 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1GAASMN1; SMN2
SCHEMBL7193542 0.74 NPC1 (0.44) TP53LMNAMEN1KMT2A
SCHEMBL17133311 0.73 ALDH1A1 (0.47) ALDH1A1KDM4ETDP1GAASMN1; SMN2
SCHEMBL10874151 0.73 CA1 (0.51) ALDH1A1KDM4ETDP1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100056432-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY POLYPHOR LTD. (CH) 2010-03-04 US disclosed
US-20100056432-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY POLYPHOR LTD. (CH) 2010-03-04 US disclosed
US-7582604-B2 Template-fixed peptidomimetics with antibacterial activity POLYPHOR LTD. (CH) 2009-09-01 US disclosed
US-7582604-B2 Template-fixed peptidomimetics with antibacterial activity POLYPHOR LTD. (CH) 2009-09-01 US disclosed
EP-1458747-B1 TEMPLATE-FIXED PEPTIDOMIMETICS AS INHIBITORS OF SERINE PROTEASES POLYPHOR LTD (CH) 2009-02-11 EP disclosed
US-7417024-B2 Template-fixed peptidomimetics as inhibitors of serine proteases POLYPHOR LTD. (CH) 2008-08-26 US disclosed
US-7417024-B2 Template-fixed peptidomimetics as inhibitors of serine proteases POLYPHOR LTD. (CH) 2008-08-26 US disclosed
US-7253146-B2 Template-fixed peptidomimetics with antimicrobial activity POLYPHOR LTD (CH) 2007-08-07 US disclosed
US-7253146-B2 Template-fixed peptidomimetics with antimicrobial activity POLYPHOR LTD (CH) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056432-A1 TEMPLATE-FIXED PEPTIDOMIMETICS WITH ANTIBACTERIAL ACTIVITY POLL, QPCTL, PEPD ALDH1A1 1705/4885KDM4E 2675/4885TDP1 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.